UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003196
Receipt number R000003871
Scientific Title Genetic analysis of prognosis-related factors in gliomas: methylation of MGMT, LOH of 1p/19q, and mutation of IDH1/2.
Date of disclosure of the study information 2010/02/22
Last modified on 2010/02/16 16:23:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Genetic analysis of prognosis-related factors in gliomas: methylation of MGMT, LOH of 1p/19q, and mutation of IDH1/2.

Acronym

Genetic analysis of prognostic factors in gliomas.

Scientific Title

Genetic analysis of prognosis-related factors in gliomas: methylation of MGMT, LOH of 1p/19q, and mutation of IDH1/2.

Scientific Title:Acronym

Genetic analysis of prognostic factors in gliomas.

Region

Japan


Condition

Condition

Glioma

Classification by specialty

Neurosurgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

Through the genetic analysis of gliomas, to evaluate the relations of the response to therapy and the prognosis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Progression free survival, Overall survival

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Take a blood sample to examine DNA in a patient's lymphocyte.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patient who has undergone definite diagnosis.

Key exclusion criteria

Who does not consent.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name KANNO, Hiroshi

Organization

Yokohama City University of Medicine

Division name

Department of Neurosurgery

Zip code


Address

3-9 Fukuura Kanazawaku Yokohama Kanagawa

TEL

045-787-2800

Email



Public contact

Name of contact person

1st name
Middle name
Last name YAMADA, Sachiko

Organization

Yokohama City University of Medicine

Division name

Department of Neurosurgery

Zip code


Address

3-9 Fukuura Kanazawaku Yokohama Kanagawa

TEL

045-787-2800

Homepage URL


Email

syamada-ykh@umin.ac.jp


Sponsor or person

Institute

Yokohama City University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Public organization

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜市立大学附属病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2010 Year 02 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 02 Month 10 Day

Date of IRB


Anticipated trial start date

2010 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 02 Month 16 Day

Last modified on

2010 Year 02 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003871


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name